Pages that link to "Q80257916"
Jump to navigation
Jump to search
The following pages link to Drug hepatotoxicity (Q80257916):
Displaying 13 items.
- Safety profile of the respiratory fluoroquinolone moxifloxacin: comparison with other fluoroquinolones and other antibacterial classes (Q28243911) (← links)
- Meta-Analysis-Based Preliminary Exploration of the Connection between ATDILI and Schizophrenia by GSTM1/T1 Gene Polymorphisms (Q28547892) (← links)
- GABA induces the differentiation of small into large cholangiocytes by activation of Ca(2+) /CaMK I-dependent adenylyl cyclase 8. (Q30542145) (← links)
- After damage of large bile ducts by gamma-aminobutyric acid, small ducts replenish the biliary tree by amplification of calcium-dependent signaling and de novo acquisition of large cholangiocyte phenotypes. (Q33745195) (← links)
- Drug-Induced Liver Injury: Cascade of Events Leading to Cell Death, Apoptosis or Necrosis (Q33755165) (← links)
- A new method for identifying causal genes of schizophrenia and anti-tuberculosis drug-induced hepatotoxicity (Q37223784) (← links)
- Granulomatous liver disease (Q37376432) (← links)
- Hepatotoxic effects of therapies for tuberculosis (Q37784382) (← links)
- Prescribing Medications in Patients with Decompensated Liver Cirrhosis (Q38345809) (← links)
- Antituberculosis drug-induced hepatotoxicity: a comparison between patients with and without human immunodeficiency virus seropositivity (Q38949370) (← links)
- CSH guidelines for the diagnosis and treatment of drug-induced liver injury (Q42354312) (← links)
- Drug-induced liver injury (Q80097388) (← links)
- Differential toxic effects of bile acid mixtures in isolated mitochondria and physiologically relevant HepaRG cells (Q91744572) (← links)